About Serum Biotec Limited
Data last updated:
Serum Biotec Limited is a public limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 October 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U00304PN1997PLC128396. Its GSTIN is 02AAECS8771R1ZN (Himachal Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8.25 Lakh. It is led by directors including Dinesh Ballbhdas Kothari (Managing Director) and Lata Dinesh Kothari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 502 Citi Centre Karve Road 39/2 Erandwane, Pune, Maharashtra, India – 411004.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.54 Cr, a decline of 41% compared to the previous year. For the same year it recorded a net profit of ₹5.14 Lakh (net margin 1.4%) and EBITDA of ₹6.46 Lakh (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 147% over three years and 23% over five years.
The company has about 18 employees on its provident fund (EPFO) records.
Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website serumbiotec.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address502 Citi Centre Karve Road 39/2 Erandwane, Pune, Maharashtra, India – 411004
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Serum Biotec Limited
The main business activity of Serum Biotec is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Serum Biotec Limited FY 2025 filings available
Serum Biotec Limited reported revenue of ₹3.54 Cr (down 41% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Serum Biotec Limited
Revenue fell 41% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 23%. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Serum Biotec Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹6.46 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.14 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Serum Biotec Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Serum Biotec are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Serum Biotec Limited
Serum Biotec Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Excellent Formulations Private Limited | ₹3.57 Cr (FY 2024) | •••• | •••• | 86.0% | •••• | New Delhi, Delhi, India |
| Ra Chem Enterprises Private Limited | ₹3.57 Cr (FY 2025) | •••• | •••• | -20.0% | •••• | Delhi, India |
| Anurag Medisales Private Limited | ₹3.57 Cr (FY 2025) | •••• | •••• | 202.0% | •••• | Howrah, West Bengal, India |
| Luvis Pharmaceuticals Private Limited | ₹3.55 Cr (FY 2024) | •••• | •••• | 3.0% | •••• | Raipur, Chhattisgarh, India |
| Nakoda Pharma Private Limited | ₹3.55 Cr (FY 2024) | •••• | •••• | -39.0% | •••• | Thane, Maharashtra, India |
| Serum Biotec Limited this company | ₹3.54 Cr (FY 2024) | •••• | •••• | -41.0% | •••• | Pune, Maharashtra, India |
| Valcret Life Sciences Private Limited | ₹3.54 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Chandigarh, India |
| Bioshield Lifesciences Private Limited. | ₹3.54 Cr (FY 2024) | •••• | •••• | -25.0% | •••• | New Delhi, Delhi, India |
| Success Ceramic Private Limited | ₹3.54 Cr (FY 2024) | •••• | •••• | 1726.0% | •••• | Vaghasia, Gujarat, India |
| Delma Innovation Private Limited | ₹3.53 Cr (FY 2024) | •••• | •••• | 37.0% | •••• | Guwahati, Assam, India |
| Medorna Health Systems Private Limited | ₹3.52 Cr (FY 2024) | •••• | •••• | 32.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Serum Biotec by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Serum Biotec Limited
Serum Biotec Limited is audited by MANTRI MARU & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MANTRI MARU & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Serum Biotec Limited
Serum Biotec has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lata Dinesh Kothari Also directs: Dawabag Private Limited, Nootan Pharmaceutical Private Limited | Director | 06 Sep 2004 | 22 Years 1 Months | Current |
| Revati Dinesh Kothari Also directs: Dawabag Private Limited | Additional Director | 27 Sep 2021 | 5 Years 0 Months | Current |
| Dinesh Ballbhdas Kothari Also directs: Dawabag Private Limited, Nootan Pharmaceutical Private Limited | Managing Director | 24 Oct 1997 | 28 Years 11 Months | Current |
Ownership and Shareholding of Serum Biotec Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Serum Biotec Limited
Serum Biotec Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Serum Biotec Limited
Serum Biotec Limited has 2 court cases on record: 2 filed against it. All cases are disposed. Status as checked between 02 Oct 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Vadodara, Gujarat | Court case (EXE S) | Filed against the company by Unicure Remedies Private Limited | Disposed |
| District court, Vadodara, Gujarat | Court case (SMCST) | Filed against the company by Unicure Remedies Private Limited | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Serum Biotec Limited
Employment history and EPFO contributions of people linked to Serum Biotec.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Serum Biotec Limited
Serum Biotec has one previous CIN (Corporate Identification Number): U00304PN2006PLC128396. The current CIN is U00304PN1997PLC128396, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U00304PN1997PLC128396 | Current |
| U00304PN2006PLC128396 | Previous |
Recent Activity on Serum Biotec Limited
Serum Biotec Limited has 6 board changes on record since 1997: 3 appointments and 3 cessations. The latest: Akash Ajay Sonar ceased to be Additional Director on 28 Sep 2021.
Credit Ratings, Litigation & Regulatory Alerts for Serum Biotec Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Serum Biotec Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Serum Biotec Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Serum Biotec Limited
Serum Biotec has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAECS8771R1ZN | Himachal Pradesh | Active | 01 Jul 2017 |
| 27AAECS8771R1ZB | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Serum Biotec Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Serum Biotec Limited
Serum Biotec is an active public limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 October 1997 (29+ years old) and is registered under CIN U00304PN1997PLC128396.
Serum Biotec reported revenue of ₹3.54 Cr for FY 2024 (down 41% YoY).
Serum Biotec has 3 current directors:
- Dinesh Ballbhdas Kothari - Managing Director
- Lata Dinesh Kothari - Director
- Revati Dinesh Kothari - Additional Director
Serum Biotec reported a net profit of ₹5.14 Lakh (net margin 1.4%) and EBITDA of ₹6.46 Lakh (EBITDA margin 1.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Serum Biotec is 147% over three years and 23% over five years. In the latest year (FY 2024) revenue fell 41%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Serum Biotec is 02AAECS8771R1ZN, registered in Himachal Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 27AAECS8771R1ZB (Maharashtra).
The CIN (Corporate Identification Number) of Serum Biotec is U00304PN1997PLC128396. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Serum Biotec has 2 court cases on record: 2 filed against it.
Serum Biotec was incorporated on 24 October 1997, making it 29+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Serum Biotec by revenue are Excellent Formulations Private Limited, Ra Chem Enterprises Private Limited, Anurag Medisales Private Limited, Luvis Pharmaceuticals Private Limited, Nakoda Pharma Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Akash Ajay Sonar ceased to be Additional Director on 28 Sep 2021. Nilesh Ballbhadas Kothari ceased to be Director on 28 Sep 2021. Vishakha Rajendra Chandak ceased to be Additional Director on 28 Sep 2021. Serum Biotec has 6 board changes on record in total.